Latest California Healthline Stories
La Casa Blanca revela norma final sobre transparencia de precios en salud
La norma establece que, a partir de 2021, los hospitales deben publicar los precios de todos sus servicios en internet, para que los consumidores tengan información.
White House Unveils Finalized Health Care Price Transparency Rule
The final directive drew swift responses from the hospital and insurance industries. The Trump administration also released a proposed rule that would require health insurers to spell out for all services beforehand just how much patients may owe for their out-of-pocket costs.
KHN’s ‘What The Health’: Spending Bill Slowdown
It’s November, do you know where your HHS spending bill is? Still stuck in Congress. Meanwhile, lawmakers move ahead on restricting tobacco products for youth while the administration’s proposal is MIA. Rebecca Adams of CQ Roll Call and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this and more health news from the week. Also, Rovner interviews Dan Weissmann, host of the podcast “An Arm and a Leg.”
Voters Say Congress Needs To Curb Drug Prices, But Are Lawmakers Listening?
Nearly 8 in 10 Americans say the cost of prescription drugs is unreasonable, but the odds look grim for Congress to pass significant pricing legislation this year.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Listen: HHS Files Challenge Over Rights To Gilead’s HIV-Prevention Drug
Kaiser Health News’ Shefali Luthra discusses the recent Trump administration lawsuit regarding the HIV-prevention drug Truvada.
Analysis: Elizabeth Warren Throws Down The Gauntlet
She has led the way, but all the candidates need to come clean about their health care proposals.
FDA Keeps Brand-Name Drugs On A Fast Path To Market ― Despite Manufacturing Concerns
The agency approved Gilead’s “game changer” hepatitis C cure, bypassing concerns raised by its own federal inspectors. The problems they found at the company’s main U.S. drug-testing laboratory in Foster City, Calif., were so bad, they recommended withholding approval.
Moved Overseas For School, Stayed For Insulin
Katie West, an American health researcher who has lived in Germany the past three years, hasn’t mastered the language and misses her family. But not having to worry about the cost of her lifesaving medication makes it OK.
Pharma Sells States On ‘Netflix Model’ To Wipe Out Hep C. But At What Price?
Manufacturers of lucrative drugs say they’re offering discounts off the high sticker prices ― but taxpayers footing the big bills might never know what the state is paying or if it’s getting a good deal.